{"id":"W4388621275","doi":"10.1159/000534303","title":"Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?","year":2023,"lang":"en","type":"article","venue":"Liver Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Oncology; Bevacizumab; Atezolizumab; Nivolumab; Adverse effect; Immunotherapy; Gastroenterology; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00137705,0.000278324,0.001318834,0.0006521085,0.0001612137,0.0007324698,0.0004863683,0.0007472375,0.002765883],"category_scores_gemma":[0.00238083,0.0001049863,0.001064868,0.0005628198,0.0003443061,0.001158086,0.000251852,0.0008998266,0.0004552289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000401986,"about_ca_system_score_gemma":0.001146478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004949622,"about_ca_topic_score_gemma":0.002070296,"domain_scores_codex":[0.9994937,0.0001957065,0.0001200985,0.00006381172,0.000102468,0.00002422567],"domain_scores_gemma":[0.9989586,0.0006121729,0.0002642395,0.00001721409,0.0001207805,0.00002697379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0007001609,0.0001058401,0.00188162,0.08657248,0.0007895301,0.0005692189,0.0001695374,0.0004837383,0.00139768,0.002282468,0.02064423,0.8844035],"study_design_scores_gemma":[0.001052196,0.001946388,0.01538752,0.1359884,0.007219234,0.01062543,0.0009015604,0.001290527,0.003341553,0.008988222,0.813104,0.0001549453],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.0009917717,0.9963996,0.000200263,0.001559032,0.0002446107,0.00001198435,0.00003405652,0.000005550626,0.0005530845],"genre_scores_gemma":[0.0119538,0.9844245,0.0006579733,0.001832147,0.0006608772,0.00003162718,0.00008829078,0.000004457755,0.0003462468],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002765883,"threshold_uncertainty_score":0.009252846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05778974049913274,"score_gpt":0.2666817629775639,"score_spread":0.2088920224784312,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}